How one clinic's practice conforms with CSM's adviceBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7030.576c (Published 02 March 1996) Cite this as: BMJ 1996;312:576
- Connie Smith
- Director of services for women Parkside Health Trust, Raymede Clinic, London W10 5SH
EDITOR,—In seeking to interpret for women the recent research showing an approximate doubling of the relative risk of venous thromboembolic disease in women taking oral contraceptives containing gestodene or desogestrel1 we need ways in which to explain the complicated and subtle statistical evidence.
John Guillebaud contends that we can reassure a woman who has been taking combined oral contraceptives for a considerable time that “as she has not had a venous thrombosis in these years she is particularly unlikely …